Aligos Therapeutics, Inc. (ALGS)
6.89
+0.09
(+1.32%)
USD |
NASDAQ |
Feb 23, 16:00
6.89
0.00 (0.00%)
After-Hours: 19:59
Aligos Therapeutics Free Cash Flow : -79.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.70B |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Agenus, Inc. | -89.31M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.34M |
| Cash from Investing (Quarterly) | 47.68M |
| Cash from Financing (Quarterly) | -0.053M |
| Free Cash Flow Per Share (Quarterly) | -2.366 |
| Free Cash Flow to Equity (Quarterly) | -23.72M |
| Free Cash Flow to Firm (Quarterly) | -24.54M |
| Free Cash Flow Yield | -129.3% |